Medable emerging biopharma
Emerging biopharma & biotech

Amplify your research

Bring speed and savings to your trials with a single platform that scales to support your study needs from beginning to end.

The capabilities of our platform and experts shift to meet your needs:

  • eConsent
  • Televisit
  • eCOA Oncology library
  • Built-in notifications and reminders
  • Life-long follow up through tokenization
  • Customer onboarding and support
  • Protocol consulting and design by oncology and eCOA trial experts

Powered by Medable


ROI for Phase III trials*


Emerging Biopharma + biotech companies

9 of 10

of the top CROs as partners

No items found.

The latest from Medable

Blog posts

What does the new European Medicine Regulatory Network recommendation paper on decentralized elements in clinical trials tell us?

Learn what impacts the new European Medicine Regulatory Network recommendations paper means to your clinical trial operations.

Blog posts

New EU Regulatory Recommendations for Decentralized Trials Keep Focus on Patients and Sites

As clinical trials rapidly modernize, government regulators work to evolve even as the same core principles apply. Still, decentralized clinical trials are – simply – clinical trials, as all research today is decentralized in some way, yet we lack global harmonization of regulations.


The digital future is now

Watch the on-demand panel discussion between Medable, Syneos, Illingworth and Veeva, moderated by Gilead, as they discuss how the next generation of clinical development is now.

See how Medable can make your trials more efficient.